Jasper Therapeutics (JSPR) Operating Leases (2020 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Operating Leases of $201000.0 for Q2 2025, down 84.38% year-over-year from $1.3 million in Q2 2024, and down 73.38% quarter-over-quarter from $755000.0 in Q1 2025.
Jasper Therapeutics (JSPR) Operating Leases (2020 - 2025) Analysis & Trends
Jasper Therapeutics' Operating Leases history runs 6 years deep, the most recent figure standing at $201000.0 for Q2 2025.
- In Q2 2025, Operating Leases fell 84.38% year-over-year to $201000.0; the TTM figure through Jun 2025 stood at $201000.0 (down 84.38% YoY), while the FY2024 annual figure was $724000.0, down 60.09% from the prior year.
- Operating Leases for Q2 2025 stood at $201000.0, down from $755000.0 in the prior quarter.
- The five-year high for Operating Leases was $3.9 million in Q3 2022, with the low at $201000.0 in Q2 2025.
- The 5-year median for Operating Leases is $1.9 million (2023), against an average of $1.9 million.
- The sharpest annual moves came in 2022 and 2025: Operating Leases soared 266.58% in 2022, then sank 84.38% in 2025.
- Jasper Therapeutics' Operating Leases stood at $760000.0 in 2021, then jumped by 266.58% to $2.8 million in 2022, then plunged by 34.89% to $1.8 million in 2023, then plunged by 60.09% to $724000.0 in 2024, then plunged by 72.24% to $201000.0 in 2025.
- Business Quant data shows JSPR's Operating Leases at $201000.0 in Q2 2025, $755000.0 in Q1 2025, and $724000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Jasper Therapeutics | 20.08 Mn | 20.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 201,000.00 |
| Mar 31, 2025 | 755,000.00 |
| Dec 31, 2024 | 724,000.00 |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.29 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 1.81 Mn |
| Sep 30, 2023 | 2.07 Mn |
| Jun 30, 2023 | 2.32 Mn |
| Mar 31, 2023 | 2.55 Mn |
| Dec 31, 2022 | 2.79 Mn |
| Sep 30, 2022 | 3.85 Mn |
| Jun 30, 2022 | 3.23 Mn |
| Mar 31, 2022 | 3.38 Mn |
| Dec 31, 2021 | 760,000.00 |
| Sep 30, 2021 | 2.51 Mn |
| Dec 31, 2020 | 1.62 Mn |